About Clairity
Clairity is a pioneering healthcare AI company dedicated to transforming medical imaging from a diagnostic tool into a predictive one for early risk assessment. Its flagship product, Clairity Breast, is the first FDA-authorized artificial intelligence platform designed to predict a woman’s five-year risk of developing breast cancer solely from a routine screening mammogram. This innovative technology leverages advanced AI and deep learning to identify subtle, often imperceptible, patterns within mammographic images, thereby enhancing the accuracy and equity of breast cancer risk prediction. By providing clinicians with actionable, personalized insights, Clairity aims to facilitate earlier interventions, reduce late-stage diagnoses, and ultimately shift the paradigm of breast cancer care from reactive detection to proactive prevention.
Beyond breast cancer, Clairity is actively expanding its platform to encompass predictive offerings for other significant diseases, including cardiovascular risk, by applying its established deep learning framework to existing imaging infrastructure. This broader vision underscores the company’s commitment to leveraging AI to improve population health outcomes and lower the overall cost of care through precision health initiatives.
Focus Areas
Business Intelligence
| Key Investors | Santé Ventures, ACE Global Equity, Breast Cancer Research Foundation (BCRF), Joe Kiani |
| Partnerships | Beth Israel Deaconess Medical Center (BIDMC), Myriad Genetics, MagView |
| Technology | AI-driven precision health, deep learning, artificial intelligence, computer vision, mammography-based AI risk prediction platform, analyzes imaging data at the pixel level, deep learning framework |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Clairity Breast offers a groundbreaking tool to significantly enhance personalized breast cancer screening and prevention strategies. It empowers you to identify high-risk women, including those under 50 and those without a strong family history, who might not be flagged by traditional risk assessments. The platform's seamless integration into existing mammography workflows, coupled with its FDA authorization and inclusion in NCCN Guidelines, provides a high level of clinical confidence. By leveraging these actionable, image-based insights, you can initiate earlier interventions, recommend supplemental imaging, or discuss risk-reduction strategies, thereby shifting the paradigm towards proactive prevention. It's crucial to remember that Clairity Breast is intended to complement, not replace, your clinical judgment and does not diagnose existing cancer or provide care recommendations.
Clairity Breast is designed for seamless integration into routine screening workflows, leveraging existing mammography images. The 5-year risk score is delivered to healthcare providers through established clinical communication channels, facilitating personalized follow-up decisions. The platform is compatible with full-field digital mammograms or directly acquired 2D images from Hologic Lorad Seleniau00ae and Seleniau00ae Dimensionsu00ae Mammography Systems. While AI models can also predict cardiovascular risk from mammograms, Clairity's primary specialization is breast cancer risk prediction.
What the Web Says
Clairity, a company operating in the healthcare IT space, receives mixed to positive reviews. Product reviews often highlight its user-friendliness and efficiency in managing healthcare data, particularly for smaller practices. Employer reviews, while fewer, suggest a generally supportive work environment, though some indicate areas for improvement in work-life balance and management communication.
Overall: MixedStrengths
- User-friendly interface for data management
- Efficient for smaller healthcare practices
- Good customer support reported by some users
- Positive impact on workflow for medical billing
- Supportive team environment (employer reviews)
- Helpful for tracking patient information
Limitations
- Limited features for larger organizations
- Occasional bugs or glitches reported
- Steep learning curve for some new users
- Pricing can be a concern for very small practices
- Work-life balance concerns (employer reviews)
- Management communication could be improved (employer reviews)
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Clairity.
Videos load interactively. If none appear, search YouTube for Clairity →
Press & Coverage
Investors
Who's funded Clairity.
Related Companies
Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
Oxipit, now a part of the Sectra Group, is a leading healthcare AI company specializing in AI-driven medical imaging solutions for radiology. Founded by experts in medicine and data science, the company aims to address the global shortage of radiologists and improve diagnostic efficiency and accuracy. Their flagship product line, the CXR Suite, includes CE-certified […]
Color Health is a healthcare AI company that operates a nationwide, oncologist-led Virtual Cancer Clinic, focusing on delivering direct clinical care across the entire cancer journey. The company aims to make cancer care more accessible, convenient, and cost-effective by providing services in cancer prevention, early detection, screening, diagnosis, active treatment management, and survivorship support. Their […]
Cercare Medical is an AI-powered healthcare company specializing in advanced perfusion imaging solutions for neurological diseases. Their software, the Cercare Medical Neurosuite, processes CT, CBCT, and MRI data to provide detailed insights into brain health. This technology goes beyond traditional perfusion imaging by integrating proprietary biomarkers that measure not only blood flow but also oxygenation, […]
CARPL.ai is a vendor-neutral Artificial Intelligence (AI) platform designed to empower radiologists by providing a unified interface for accessing, assessing, integrating, and monitoring AI solutions within their clinical workflows. The platform addresses the challenges healthcare providers face in navigating the fragmented landscape of numerous AI applications by offering a single point of access, data channel, […]
Smart Soft Healthcare is a healthcare startup dedicated to transforming spine diagnostics and treatment through Artificial Intelligence (AI). Established in 2021 as a spin-off from SmartSoft, the company aims to deliver more effective and economical healthcare solutions. Their primary product, CoLumbo, is an AI-powered software designed to assist in the interpretation of lumbar spine MRI […]